OHSU News

This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.

OHSU to provide new, FDA-approved gene therapy for a form of blindness

OHSU to provide new, FDA-approved gene therapy for a form of blindness

OHSU will be one of just four institutions nationwide to initially provide a new gene therapy treatment for a form of blindness that affects both children and adults.